StockVS

NYSE · Medical Care Facilities · USD

Chemed Corporation (CHE) Stock Analysis

Chemed Corporation (CHE) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.

CHE

$519.84

−$4.61 (−0.88%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CHE with… →

CHE Key Statistics

As of Sep 4, 2026
Trading
Open
$519.62
Previous Close
$524.45
Day's Range
519.23–525.63
52-Week Range
365.21–557.00
Volume
84.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.51
Valuation
Market Cap
$6.79B
P/E Ratio
26.39
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
18.89
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.91
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.62
EPS (ttm)Profit attributable to each share over the last twelve months.
19.70
Financials (FY)
Revenue (FY)
$2.53B+4.06%
Net Income (FY)
$265.24M−12.17%
Profit marginThe share of revenue left as profit after all costs and taxes.
10.60%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
13.07M
1-Year Return
+13.54%
Dividend and dates
Dividend
$2.80+0.53%
Ex-Dividend Date
August 17, 2026
Earnings Date
October 27, 2026
Avg Volume
181.26K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CHE Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+21.82%
2025−18.87%
2024−9.11%
2023+14.90%
2022−3.22%
2021−0.38%
2020+21.59%
2019+55.58%
2018+17.01%
2017+52.32%
2016 (partial year)+11.91%

As of September 4, 2026.

CHE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.53B$265.24M10.5%
2024$2.43B$302.00M12.4%
2023$2.26B$272.51M12.0%
2022$2.13B$249.62M11.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.53B$823.18M$341.16M$265.24M10.5%
2024$2.43B$854.35M$366.94M$302.00M12.4%
2023$2.26B$798.82M$342.83M$272.51M12.0%
2022$2.13B$765.09M$347.19M$249.62M11.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CHE Dividend History

$2.20+22.2% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.903
2025$2.204+22.2%
2024$1.804+15.4%
2023$1.564+5.4%
YearDividends per sharePaymentsChange
2026 (partial year)$1.903
2025$2.204+22.2%
2024$1.804+15.4%
2023$1.564+5.4%
2022$1.484+5.7%
2021$1.404+6.1%
2020$1.324+6.5%
2019$1.244+6.9%
2018$1.164+7.4%
2017$1.084+315.4%
2016$0.261

Most recent payment: $0.63 per share, ex-dividend August 17, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CHE Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricCHEMedical Care Facilities medianvs median
P/E26.3919.8433% above
P/S ratio2.620.95175% above
Profit margin10.60%3.06%7.5 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Chemed Corporation (CHE) carries a market capitalisation of $6.79B. The company sits in the Healthcare sector, in the Medical Care Facilities industry. Headcount on file is 15,811.

The 52-week range on file runs from $365.21 to $557.00. The most recent close on file for CHE is $519.84, dated September 4, 2026. That is −$4.61 (−0.88%) against the previous close. The latest close sits 42.34% above that 52-week low.

Financial Health

In fiscal 2025, Chemed Corporation reported revenue of $2.53B. Against the prior fiscal year total of $2.43B, that is a change of +4.06%. The same year closed with net income of $265.24M. That is −12.17% against the prior fiscal year. The reported profit margin is 10.6%. That is 7.5 percentage points above the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to 19.7.

Across the 4 fiscal years on file, revenue moves from $2.13B in 2022 to $2.53B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

CHE trades at a trailing price-to-earnings ratio of 26.39. That is 33.01% above the Medical Care Facilities median of 19.84. On forward earnings the ratio is 18.89. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.91. Measured against sales, the shares trade at 2.62 times revenue. On price-to-sales that is 175.47% above the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

Over the trailing twelve months the price has returned +13.54%. Across 10 years the annualized return works out at +14.66%. Beta against the wider market is reported at 0.51. Annualized volatility over the trailing 10 years is 25.99%.

Growth & Income

CHE pays a dividend yielding 0.53%. That is 1 percentage points below the Medical Care Facilities median yield of 1.51%. The indicated annual rate is $2.80 a share. The ex-dividend date on file is August 17, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.90 a share. The year before, 2025, totalled $2.20 a share.

So far in 2026 the price is +21.82%. Across the complete calendar years on file, 2019 returned +55.58% and 2025 returned −18.87%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

Chemed Corporation (CHE) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Chemed Corporation CHE $6.79B 26.4
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. Chemed Corporation trades at a P/E of 26.4.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

View all Medical Care Facilities stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Visit website →